Desflurane Protects The Brain Against The Oxidant Activity of Acute Hyperglycemia in Diabetic Rats, Comparison with Sevoflurane

Year 2023, Volume: 5 Issue: 1, 34 - 41, 30.04.2023

Alican Kaya , Mustafa Arslan , Elif Beşkardeş , Ömer Kurtipek , Dilek Kalaycı , Alper Tunga Dogan , Ayşe Hande Arpacı , Işın Güneş , Mustafa Kavutcu

https://doi.org/10.59124/guhes.1223446

Abstract

In this study, we investigated the effects of sevoflurane and desflurane administration on the oxidant and antioxidant system in the brain of acute hyperglycemia in diabetic rats. In the study, 30 male Wistar Albino rats were randomly divided into five groups. Diabetes was induced by administering a single dose of intraperitoneal streptozotocin (55 mg/kg) to rats except for the control group (C). To create acute hyperglycemia in diabetic groups, which were hyperglycemia (DH), desflurane (D), and sevoflurane (S) groups, 2.5 g/kg glucose was administered intraperitoneally. After glucose administration, desflurane 6% and sevoflurane 2.3% mixed with 4 L/min oxygen were administered for 2 hours, by which minimal alveolar concentration for rats would be one. Afterward, the animals were sacrificed, and their brain tissues were prepared for biochemical analysis. Catalase (CAT), glutathione-s-transferase (GST), paraoxonase (PON) activities, and TBARS levels were measured to determine oxidant and antioxidant status. GST activity was significantly lower in group D than in group DH (p=0.001). The PON activity was significantly lower in the D group compared with other groups (p<0.001). In the S group, PON activity was significantly lower than in the diabetic control (DC) group and DH groups (p=0.022, p=0.020, respectively). TBARS level was significantly lower in group D than in group DH (p=0.013). As a result, desflurane decreases GST and PON activity and TBARS levels more than sevoflurane. In terms of lipid peroxidation, desflurane shows more protective properties than sevoflurane. Since our study is the first study in this field, it should be supported by other studies to be carried out.

Keywords

Antioxidant system, Brain, Desflurane, Diabetes Mellitus, Sevoflurane

References

• Aebi, H. (1984). [13] Catalase in vitro. In Methods in enzymology (Vol. 105, pp. 121-126): Elsevier.
• Akin, M., Ayoglu, H., Okyay, D., Ayoglu, F., Gür, A., Can, M., Yurtlu, S., Hancı, V., Küçükosman, G., Turan, I. (2015). Effects of various anesthesia maintenance on serum levels of selenium, copper, zinc, iron and antioxidant capacity. Revista Brasileira de Anestesiologia, 65, 51-60.
• Butterworth Iv, J. F., Mackey, D. C., & Wasnick, J. D. (2022). Inhalation Anesthetics. In Morgan &amp; Mikhail’s Clinical Anesthesiology, 7e. New York, NY: McGraw-Hill Education.
• Choi, S.-W., Benzie, I. F., Ma, S.-W., Strain, J., & Hannigan, B. M. (2008). Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radical Biology and Medicine, 44(7), 1217-1231.
• Claiborne, A. (2018). Catalase activity. In CRC handbook of methods for oxygen radical research (pp. 283-284): CRC press.
• Dikmen, B., Unal, Y., Pampal, H. K., Nurlu, N., Kurtipek, O., Canbolat, O., Ozoğul, C., Kavutcu, M. (2007). Effects of repeated desflurane and sevoflurane anesthesia on enzymatic free radical scavanger system. Molecular and Cellular Biochemistry, 294(1), 31-36.
• Erbas, M., Demiraran, Y., Yildirim, H. A., Sezen, G., Iskender, A., Karagoz, I., & Kandis, H. (2015). Comparison of effects on the oxidant/antioxidant system of sevoflurane, desflurane and propofol infusion during general anesthesia. Revista Brasileira de Anestesiologia, 65, 68-72.
• Galindo, R. J., Fayfman, M., & Umpierrez, G. E. (2018). Perioperative management of hyperglycemia and diabetes in cardiac surgery patients. Endocrinology and Metabolism Clinics, 47(1), 203-222.
• Habig, W. H., Pabst, M. J., & Jakoby, W. B. (1974). Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 249(22), 7130-7139.
• Irshad, M., & Chaudhuri, P. (2002). Oxidant-antioxidant system: role and significance in human body.
• Koksal, G., Sayilgan, C., Aydin, S., Uzun, H., & Oz, H. (2004). The effects of sevoflurane and desflurane on lipid peroxidation during laparoscopic cholecystectomy. European Journal of Anaesthesiology, 21(3), 217-220.
• Liang, T.-Y., Peng, S.-Y., Ma, M., Li, H.-Y., Wang, Z., & Chen, G. (2021). Protective effects of sevoflurane in cerebral ischemia reperfusion injury: a narrative review. Medical Gas Research, 11(4), 152.
• Molin, S. Z. F. D., Kruel, C. R. P., de Fraga, R. S., Alboim, C., de Oliveira, J. R., & Alvares-da-Silva, M. R. (2014). Differential protective effects of anaesthesia with sevoflurane or isoflurane: An animal experimental model simulating liver transplantation. European Journal of Anaesthesiology | EJA, 31(12). Retrieved from https://journals.lww.com/ejanaesthesiology/Fulltext/2014/12000/Differential_protective_effects_of_anaesthesia.7.aspx
• Nair, S. P., Shah, N., Taggarsi, A., & Nayak, U. (2011). PONI and its association with oxidative stress in type I and type II diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 5(3), 126-129.
• Parmaksız, İ., Atak, P. G., Yavuz, D. G., & Şirikçi, Ö. (2011). Streptozotosin ile diyabet oluşturulmuş sıçanlarda aminoguanidinin serum paraoksonaz aktivitesi üzerine etkisi. Turkish Journal of Biochemistry/Turk Biyokimya Dergisi, 36(4).
• Santos-Sánchez, N. F., Salas-Coronado, R., Villanueva-Cañongo, C., & Hernández-Carlos, B. (2019). Antioxidant compounds and their antioxidant mechanism. Antioxidants, 10, 1-29.
• Sato, N., Fujii, K., & Yuge, O. (1994). In Vivo and In Vitro Sevoflurane‐Induced Lipid Peroxidation in Guinea‐pig Liver Microsomes. Pharmacology & Toxicology, 75(6), 366-370.
• Shilling, A. M., & Raphael, J. (2008). Diabetes, hyperglycemia, and infections. Best Practice & Research Clinical Anaesthesiology, 22(3), 519-535.
• Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., . . . Mbanya, J. C. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183, 109119.
• Turina, M., Fry, D. E., & Polk Jr, H. C. (2005). Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Critical Care Medicine, 33(7), 1624-1633.
• Türkan, H., Aydin, A., Sayal, A., Eken, A., Akay, C., & Karahalil, B. (2011). Oxidative and Antioxidative Effects of Desflurane and Sevoflurane on Rat Tissue. Archives of Industrial Hygiene and Toxicology, 62(2), 113-119.
• Van Ye, T. M., Roza, A. M., Pieper, G. M., Henderson, J., Johnson, C. P., & Adams, M. B. (1993). Inhibition of intestinal lipid peroxidation does not minimize morphologic damage. Journal of Surgical Research, 55(5), 553-558.
• Watanabe, H., Kamagata, C., Tsuboko, Y., & Sakamoto, A. (2012). Volatile and Intravenous Anesthesia Alter Rat Liver Proteins: Proteomic Time Course Analysis of Rat Liver Proteins. The Open Proteomics Journal, 5(1).
• Wei, W., Liu, Q., Tan, Y., Liu, L., Li, X., & Cai, L. (2009). Oxidative stress, diabetes, and diabetic complications. Hemoglobin, 33(5), 370-377.
• Wong, C. H., Liu, T.-Z., Chye, S.-M., Lu, F.-J., Liu, Y.-C., Lin, Z.-C., & Chen, C.-H. (2006). Sevoflurane-induced oxidative stress and cellular injury in human peripheral polymorphonuclear neutrophils. Food and Chemical Toxicology, 44(8), 1399-1407.
• Yaribeygi, H., Sathyapalan, T., Atkin, S. L., & Sahebkar, A. (2020). Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxidative Medicine and Cellular Longevity, 2020.
• Yehuda, I., Madar, Z., Leikin‐Frenkel, A., Szuchman‐Sapir, A., Magzal, F., Markman, G., & Tamir, S. (2016). Glabridin, an isoflavan from licorice root, upregulates paraoxonase 2 expression under hyperglycemia and protects it from oxidation. Molecular Nutrition & Food Research, 60(2), 287-299.
• Yue, T., Shanbin, G., Ling, M., Yuan, W., Ying, X., & Ping, Z. (2015). Sevoflurane aggregates cognitive dysfunction and hippocampal oxidative stress induced by β-amyloid in rats. Life Sciences, 143, 194-20.